688278 特寶生物
按盤價 
74.760 -1.030 (-1.359%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.869 | 37.366 | 33.828 | 22.346 | 16.765 |
| 總資產報酬率 ROA (%) | 5.847 | 30.615 | 26.925 | 17.972 | 13.848 |
| 投入資產回報率 ROIC (%) | 6.580 | 35.660 | 32.277 | 21.400 | 16.036 | 邊際利潤分析 |
| 銷售毛利率 (%) | 93.174 | 93.486 | 93.332 | 88.916 | 88.948 |
| 營業利潤率 (%) | 32.667 | 34.458 | 32.410 | 26.650 | 21.950 |
| 息稅前利潤/營業總收入 (%) | 30.795 | 32.971 | 30.274 | 23.037 | 18.918 |
| 淨利潤/營業總收入 (%) | 27.048 | 29.377 | 26.446 | 18.797 | 16.004 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.623 | 100.511 | 103.762 | 101.885 | 102.294 |
| 價值變動淨收益/利潤總額(%) | 0.667 | 0.530 | 0.967 | 1.101 | 3.151 |
| 營業外收支淨額/利潤總額(%) | -5.138 | -4.265 | -6.254 | -14.328 | -15.441 | 償債能力分析 |
| 流動比率 (X) | 5.557 | 4.344 | 3.320 | 3.567 | 4.708 |
| 速動比率 (X) | 4.731 | 3.717 | 2.857 | 3.083 | 4.051 |
| 資產負債率 (%) | 13.521 | 16.296 | 20.359 | 20.469 | 18.461 |
| 帶息債務/全部投入資本 (%) | 1.273 | 1.344 | 1.194 | -2.475 | -2.488 |
| 股東權益/帶息債務 (%) | 7,523.374 | 7,125.567 | 7,950.842 | -3,880.651 | -3,836.142 |
| 股東權益/負債合計 (%) | 639.607 | 513.644 | 391.173 | 388.546 | 441.687 |
| 利息保障倍數 (X) | -111.665 | -426.964 | -132.170 | -84.160 | -196.146 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 95.268 | 77.268 | 56.125 | 47.562 | 55.529 |
| 存貨周轉天數 (天) | 537.485 | 441.944 | 407.086 | 261.874 | 310.866 |
| 備註： | 即時報價更新時間為 14/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
